MD1166Y - Metodă de testare a sângelui donatorului la markerii hepatitei virale B - Google Patents

Metodă de testare a sângelui donatorului la markerii hepatitei virale B

Info

Publication number
MD1166Y
MD1166Y MDS20170004A MDS20170004A MD1166Y MD 1166 Y MD1166 Y MD 1166Y MD S20170004 A MDS20170004 A MD S20170004A MD S20170004 A MDS20170004 A MD S20170004A MD 1166 Y MD1166 Y MD 1166Y
Authority
MD
Moldova
Prior art keywords
markers
blood
viral hepatitis
donor blood
testing
Prior art date
Application number
MDS20170004A
Other languages
English (en)
Russian (ru)
Inventor
Константин СПЫНУ
Октавиан САЖЕН
Юрие ПЫНЗАРУ
Светлана ЧЕБОТАРЬ
Игорь СПЫНУ
Кристина ЖОСАНУ
Виктор ПЫНТЯ
Луминица СУВЕЙКА
Original Assignee
Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова filed Critical Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова
Priority to MDS20170004A priority Critical patent/MD1166Z/ro
Publication of MD1166Y publication Critical patent/MD1166Y/ro
Publication of MD1166Z publication Critical patent/MD1166Z/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Invenţia se referă la medicină şi poate fi utilizată pentru testarea sângelui donatorului la markerii hepatitei virale B cu scop de prevenire a infectării în cazul transfuziei de sânge.Esenţa invenţiei constă în aceea că în sânge se determină succesiv prezenţa antigenului AgHBs, anticorpilor antiHBcor sumar, antiHBcor IgM şi antiHBs, iar pentru sângele cu titrul la antiHBs mai mare de 100 mUI/ml, suplimentar se efectuează testul la ADN al virusului hepatitei B şi în cazul în care testul este pozitiv, se stabileşte prezenţa markerilor hepatitei virale B în sângele donatorului.
MDS20170004A 2017-01-19 2017-01-19 Metodă de testare a sângelui donatorului la markerii hepatitei virale B MD1166Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20170004A MD1166Z (ro) 2017-01-19 2017-01-19 Metodă de testare a sângelui donatorului la markerii hepatitei virale B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20170004A MD1166Z (ro) 2017-01-19 2017-01-19 Metodă de testare a sângelui donatorului la markerii hepatitei virale B

Publications (2)

Publication Number Publication Date
MD1166Y true MD1166Y (ro) 2017-07-31
MD1166Z MD1166Z (ro) 2018-02-28

Family

ID=59383898

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20170004A MD1166Z (ro) 2017-01-19 2017-01-19 Metodă de testare a sângelui donatorului la markerii hepatitei virale B

Country Status (1)

Country Link
MD (1) MD1166Z (ro)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU712091A1 (ru) * 1978-07-31 1980-01-30 Рижский Медицинский Институт Способ определени антигена или антител е вируса гепатита в
DE3705512A1 (de) * 1987-02-20 1988-09-01 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
SU1642399A1 (ru) * 1988-12-27 1991-04-15 Институт Органического Синтеза Ан Латвсср Способ определени антител класса I @ М к корантигену вируса гепатита В
SU1704088A1 (ru) * 1989-06-27 1992-01-07 Нижегородский государственный медицинский институт им.С.М.Кирова Способ прогнозировани хронического вирусного гепатита В
SU1751680A1 (ru) * 1990-03-11 1992-07-30 Нижегородский медицинский институт им.С.М.Кирова Способ прогнозировани развити хронического гепатита В
MD34Z5 (ro) * 2008-05-20 2010-01-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de diagnostic al hepatitei virale B la copii de până la un an
MD975Z (ro) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de determinare a markerilor hepatitei virale B în sângele donatorului

Also Published As

Publication number Publication date
MD1166Z (ro) 2018-02-28

Similar Documents

Publication Publication Date Title
Gisbert et al. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease
Tsoi et al. Enhanced detection of hepatitis B virus in H ong K ong blood donors after introduction of a more sensitive transcription‐mediated amplification assay
Arnold et al. Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia
Coppola et al. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient
Alizadeh et al. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study
Kose et al. Seroprevalence of hepatitis B and C among oncology patients in Turkey
Bogler et al. Epidemiology and natural history of chronic hepatitis B virus infection
Khamesipour et al. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran
Mulrooney-Cousins et al. Asymptomatic hepadnaviral persistence and its consequences in the woodchuck model of occult hepatitis B virus infection
MD975Z (ro) Metodă de determinare a markerilor hepatitei virale B în sângele donatorului
MD1166Y (ro) Metodă de testare a sângelui donatorului la markerii hepatitei virale B
Aghasadeghi et al. No evidence for occult HBV infection in hepatitis B vaccine non-responders
Rezahosseini et al. Torque-Teno virus to optimize timing of vaccination against severe acute respiratory syndrome coronavirus 2 in solid organ transplant recipients
Kalantari et al. Prevalence of hepatitis C virus, hepatitis B virus, human immunodeficiency virus and related risk factors among hemophilia and thalassemia patients In Iran
Al Jadiry et al. High incidence of hepatitis B infection after treatment for paediatric cancer at a teaching hospital in Baghdad
Chakraborty et al. Persistence of anti-HBs antibody and immunological memory in healthy individuals vaccinated with Hepatitis B vaccine
Wang et al. Nucleoside analogues alone or combined with vaccination prevent hepadnavirus viremia and induce protective immunity: alternative strategy for hepatitis B virus post-exposure prophylaxis
Rinaldi et al. B-sides serologic markers of immunogenicity in kidney transplanted patients: report from 2012–2013 flu vaccination experience
Leung et al. A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT.
Aggarwal et al. Prevalence of hepatitis B and hepatitis C infections in patients and healthy blood Donors
De Paschale et al. Presence of anti-HBs antibodies in blood donors 18–22 years after vaccination and implications for the selection of candidates for plasmapheresis for the production of hyperimmune plasma
Barone et al. Lesson from an intriguing case of cryoglobulinemia
Atalay et al. Hepatitis B and C Sero-prevalence in Patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome at a Tertiary Care Hospital in Izmir
Solanki et al. Seroprevalence of HIV in blood donors at tertiary care center, MYH Indore, India
Huh et al. Improvement of the Accuracy of Hepatitis B Surface Antigen Testing Using a Confirmatory Test

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired